• Profile
Close

Hepatic steatosis has no effect in diagnosis accuracy of LI-RADS v2018 categorization of hepatocellular carcinoma in MR imaging

Journal of Magnetic Resonance Imaging Jun 17, 2021

Yao S, Wei Y, Ye Z, et al. - A prospective study was conducted to explore and compare the differences in hepatocellular carcinoma (HCC) related imaging features between with- and without-hepatic steatosis (HS) groups, and to further determine whether HS affects the diagnosis accuracy of Liver Imaging Reporting and Data System (LI-RADS) v2018 of HCC in MRI. Researchers enrolled a total of 171 patients (mean age, 52 ± 11 years; range, 26–83 years) including 137 men and 34 women. Individuals were categorized as HS and non-HS groups according to MRI-proton density fat-fraction (PDFF). The results of this study demonstrate that diagnosis of HCC based on LI-RADS v2018 in MRI is of comparable performance regardless of HS, in which there is no significant difference in either the major imaging features or LR categorization.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay